Copyright
©The Author(s) 2019.
World J Gastroenterol. Sep 28, 2019; 25(36): 5530-5542
Published online Sep 28, 2019. doi: 10.3748/wjg.v25.i36.5530
Published online Sep 28, 2019. doi: 10.3748/wjg.v25.i36.5530
Table 4 RAF/PTPRD/CTNNB1/RNF43/POLD1/TP53 mutations in cystic fluid and final diagnosis
| RAF/PTPRD/CTNNB1/RNF43/POLD1/TP53 mutations in cystic fluid, n = 17 | Cancer | No cancer |
| Positive (+) | ||
| Population size, n | 5 | 0 |
| Patient codes | True positive: 10, 13, 17, 18, 19 | False positive |
| Negative mutations (-) | ||
| Population size, n | 4 | 8 |
| Patient codes | False negative: 1, 9, 14, 15 | True negative: 2, 3, 4, 5, 6, 8, 16, 20 |
| Total population, n | 9 | 8 |
- Citation: Laquière A, Lagarde A, Napoléon B, Bourdariat R, Atkinson A, Donatelli G, Pol B, Lecomte L, Curel L, Urena-Campos R, Helbert T, Valantin V, Mithieux F, Buono JP, Grandval P, Olschwang S. Genomic profile concordance between pancreatic cyst fluid and neoplastic tissue. World J Gastroenterol 2019; 25(36): 5530-5542
- URL: https://www.wjgnet.com/1007-9327/full/v25/i36/5530.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i36.5530